FBT

First Trust NYSE Arca Biotechnology Index Fund

Down$146.70
$-1.77
(-1.19%)
As of 11:58:04 AM EDT | 1/24/20  |  Market Open

FBT Trading Data

Open

$149.05

Low Price

$146.56

High Price

$149.24

Previous Last Price

$148.47

Bid Size

$146.78 X 100

Ask Size

$146.95 X 300

FBT Portfolio Data

AUM

$1,820,105,000

Shares

12,250

PE Ratio

22.49

Price / Book Ratio

4.9

Expense Ratio

0.57

Net Asset Value

$148.58

Volume

Volume

11,441

Avg. Volume (YDT)

91,335

Dollar Volume

$13,877,001

Weekly Avg. Volume

64,113

Monthly Avg. Volume

81,528

Quarterly Avg. Volume

82,725

FBT Fund Description

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July and October to ensure that each component stock continues to represent approximately equal weight in the index.

FBT Chart

FBT Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust NYSE Arca Biotechnology Index Fund

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

FBT Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

FBT Holdings

Top 10 Holdings

Exact Sciences Corporation (EXAS)
0.04%
Seattle Genetics Inc. (SGEN)
0.03%
Illumina Inc. (ILMN)
0.03%
Ionis Pharmaceuticals Inc. (IONS)
0.03%
Agios Pharmaceuticals Inc. (AGIO)
0.03%
Biogen Inc. (BIIB)
0.03%
Gilead Sciences Inc. (GILD)
0.03%
Exelixis Inc. (EXEL)
0.03%
Vertex Pharmaceuticals Incorporated (VRTX)
0.03%
BioMarin Pharmaceutical Inc. (BMRN)
0.03%

Total FBT Holdings

Total Holdings: 32

Exact Sciences Corporation (EXAS)
0.04%
Seattle Genetics Inc. (SGEN)
0.03%
Illumina Inc. (ILMN)
0.03%
Ionis Pharmaceuticals Inc. (IONS)
0.03%
Agios Pharmaceuticals Inc. (AGIO)
0.03%
Biogen Inc. (BIIB)
0.03%
Gilead Sciences Inc. (GILD)
0.03%
Exelixis Inc. (EXEL)
0.03%
Vertex Pharmaceuticals Incorporated (VRTX)
0.03%
BioMarin Pharmaceutical Inc. (BMRN)
0.03%
Bio-Techne Corporation (TECH)
0.03%
Charles River Laboratories International Inc. (CRL)
0.03%
IQVIA Holdings Inc. (IQV)
0.03%
United Therapeutics Corporation (UTHR)
0.03%
Grifols S.A. (ADR) (GRFS)
0.03%
FibroGen Inc. (FGEN)
0.03%
Neurocrine Biosciences Inc. (NBIX)
0.03%
Alexion Pharmaceuticals Inc. (ALXN)
0.03%
Nektar Therapeutics (NKTR)
0.03%
Amgen Inc. (AMGN)
0.03%
Incyte Corporation (INCY)
0.03%
QIAGEN N.V. (QGEN)
0.03%
Ulagenyx Pharmaceutical Inc. (RARE)
0.03%
ACADIA Pharmaceuticals Inc. (ACAD)
0.03%
Alnylam Pharmaceuticals Inc. (ALNY)
0.03%
Alkermes Plc (ALKS)
0.03%
bluebird bio Inc. (BLUE)
0.03%
Intercept Pharmaceuticals Inc. (ICPT)
0.03%
Regeneron Pharmaceuticals Inc. (REGN)
0.03%
Sarepta Therapeutics Inc. (SRPT)
0.03%
First Trust Amex Biotech Index Fund ETF (FBT)
0%
US Dollar ($USD)
0%

FBT Technicals

Alpha

-0.1

Beta

1.48

Leverage

Long

Standard Deviation

8.6

FBT Dividends

Dividend Date

2015-09-23

Latest Dividend

0.02

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FBT Performance

YTD Return

-1.45%

1 Year Return

4.08%

3 Year Return

57.73%

5 Year Return

35.1%

10 Year Return

407.59%

FBT Related Articles

© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.